GLPBio

Ceapin-A7

Catalog No.: GC61606Purity:>98.00%

Ceapin-A7 ist ein selektiver Blocker des ATF6α-Signalwegs als Reaktion auf ER-Stress mit einer IC50 von 0,59 μM.

Die Produkte sind ausschließlich für Forschungszwecke bestimmt. Nicht zur Anwendung am Menschen. Wir verkaufen nicht an Patienten.


Ceapin-A7
Cas No.: 2323027-38-7
10mM (in 1mL DMSO)In Stock
$74.00
1
1mgIn Stock
$36.00
1
5mgIn Stock
$68.00
1
10mgIn Stock
$108.00
1
25mgIn Stock
$207.00
1
50mgIn Stock
$331.00
1
100mgIn Stock
$530.00
1

Zitate (Citations)

Für dieses Produkt sind derzeit keine Zitate verfügbar. Nachfolgend finden Sie ausgewählte Publikationen, die GlpBio-Produkte zitieren.
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

Beschreibung (Description)

Ceapin-A7 is a selective blocker of endoplasmic reticulum stress ATF6α signaling (IC50= 0.59μM)[1]. Ceapin-A7 can inhibit Th17 cell differentiation[2]. Ceapin-A7 protects cells from Zika virus infection and also has the function of increasing the radiosensitivity of cancer cells[3-4].

In vitro, pretreatment of ccRCC cells (ACHN and 786-O) with Ceapin-A7 (20μM) for 24 hours reduced the protein expression of PINK1 and BNIP3, and promoted cell proliferation and migration[5]. Pretreatment of bovine pulmonary artery endothelial cells (BPAEC) with Ceapin-A7 (15μM) for 24 hours, followed by stimulation with LPS (1μg/ml) for 2 hours, significantly enhanced the phosphorylation activation of STAT3, JAK2, and JNK, while exacerbating the inhibition of cell proliferation[6].

In vivo, Ceapin-A7 (10mg/kg) was administered via intraperitoneal injection three times per week to DBA/1J mice with collagen-induced arthritis (CIA), from day 22 to day 45, Ceapin-A7 significantly alleviated arthritis severity and joint bone erosion[7]. Ceapin-A7 (1μM) was administered via drinking water to curdlan-induced SKG mice, from week 1 until week 12. Ceapin-A7 significantly alleviated spinal ankylosis and osteophyte formation[8].

References:
[1] Fakir S, Sigdel M, Sarker MMR, et al. Ceapin-A7 suppresses the protective effects of Octreotide in human and bovine lung endothelial cells. Cell Stress Chaperones. 2025 Feb;30(1):1-8.
[2] Kubra KT, Akhter MS, Saini Y, et al. Activating transcription factor 6 protects against endothelial barrier dysfunction. Cell Signal. 2022 Nov;99:110432.
[3] Kern J, Schilling D, Schneeweis C, et al. Identification of the unfolded protein response pathway as target for radiosensitization in pancreatic cancer. Radiother Oncol. 2024 Feb;191:110059.
[4] Mufrrih M, Chen B, Chan SW. Zika Virus Induces an Atypical Tripartite Unfolded Protein Response with Sustained Sensor and Transient Effector Activation and a Blunted BiP Response. mSphere. 2021 Jun 30;6(3):e0036121.
[5] Yan M, Wang J, Wang H, et al. Knockdown of NR3C1 inhibits the proliferation and migration of clear cell renal cell carcinoma through activating endoplasmic reticulum stress-mitophagy. J Transl Med. 2023 Oct 8;21(1):701.
[6] Kubra KT, Barabutis N. Ceapin-A7 potentiates lipopolysaccharide-induced endothelial injury. J Biochem Mol Toxicol. 2023 Nov;37(11):e23460.
[7] Ge L, Wang T, Shi D, et al. ATF6α contributes to rheumatoid arthritis by inducing inflammatory cytokine production and apoptosis resistance. Front Immunol. 2022 Oct 10;13:965708.
[8] Ma M, Li H, Wang P, et al. ATF6 aggravates angiogenesis-osteogenesis coupling during ankylosing spondylitis by mediating FGF2 expression in chondrocytes. iScience. 2021 Jun 28;24(7):102791.

Protokoll (Protocol)

Cell experiment [1]:

Cell lines

ACHN and 786-O cells (human renal cell carcinoma cell lines)

Preparation Method

ACHN and 786-O cells were maintained in RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS) at 37°C, 5% CO₂. Cells were treated with Ceapin-A7 at a concentration of 20μM for 5 hours.

Reaction Conditions

20μM; 5h

Applications

Ceapin-A7 significantly down-regulated the expression of PINK1 and BNIP3 in NR3C1-knockdown ccRCC cells. Ceapin-A7 also reversed the increased LC3 expression and decreased P62 expression induced by NR3C1 knockdown, indicating inhibition of mitophagy. Additionally, Ceapin-A7 treatment rescued the reduced proliferation and migration capabilities of ccRCC cells caused by NR3C1 knockdown.

Animal experiment [2]:

Animal models

DBA/1J mice with collagen-induced arthritis (CIA)

Preparation Method

CIA mice were intraperitoneally administered Ceapin-A7 (10mg/kg) three times per week from day 22 to day 45 post-immunization. Control groups received vehicle or etanercept (2mg/kg).

Dosage form

10mg/kg/day; i.p.

Applications

Ceapin-A7 administration significantly reduced arthritis severity scores and paw swelling in CIA mice, comparable to etanercept treatment. Ceapin-A7 treatment decreased bone erosion parameters (Tb.Sp) while increasing bone mineral density (Tb.BMD) and trabecular number (Tb.N). Additionally, Ceapin-A7 reduced serum levels of inflammatory cytokines including IL-6, IL-8, TNF-α and IL-1β. Histological analysis showed Ceapin-A7 ameliorated synovial hyperplasia, pannus formation and cartilage destruction.

References:
[1] Yan M, Wang J, Wang H, et al. Knockdown of NR3C1 inhibits the proliferation and migration of clear cell renal cell carcinoma through activating endoplasmic reticulum stress-mitophagy. J Transl Med. 2023 Oct 8;21(1):701.
[2] Ge L, Wang T, Shi D, et al. ATF6? contributes to rheumatoid arthritis by inducing inflammatory cytokine production and apoptosis resistance. Front Immunol. 2022 Oct 10;13:965708.

Produktdokumente (Product Documents)

Purity:>98.00%Appearance:A solid

Chemische Eigenschaften (Chemical Properties)

CAS-Nr.
2323027-38-7
SMILES
O=C(NC1=CN(CC2=CC=C(C(F)(F)F)C=C2C(F)(F)F)N=C1)C3=NOC(C4=CC=CO4)=C3
Summenformel
C20H12F6N4O3
Molekulargewicht
470.32
Löslichkeit
DMSO: 100 mg/mL (212.62 mM)
Lagerung
Store at -20°C
Allgemeine Hinweise
Wählen Sie anhand der Löslichkeitsdaten des Produkts ein geeignetes Lösungsmittel. Aliquotieren Sie die Stammlösung nach der Herstellung, um wiederholte Gefrier-Auftau-Zyklen zu vermeiden.
Verwenden Sie Stammlösungen bei Lagerung bei -80°C innerhalb von 6 Monaten bzw. bei -20°C innerhalb von 1 Monat.
Zur Verbesserung der Löslichkeit das Röhrchen auf 37°C erwärmen und für eine angemessene Dauer beschallen.
Versandbedingungen
Evaluierungsmuster werden mit Kühlakkus versandt. Andere verfügbare Größen werden bei Raumtemperatur oder auf Anfrage mit Kühlakkus versandt.

Rechner (Calculators)Molarität / Verdünnung / Molekulargewicht / Einheitenumrechnung / In-vivo-Formulierung / Löslichkeit

g/mol

Reviews

Review for Ceapin-A7

Rating: 5
  • 5 Star100%
  • 4 Star0%
  • 3 Star0%
  • 2 Star0%
  • 1 Star0%